WBCIL's impact on API and nutraceutical industries
Times of India | 9 July 2024
West Bengal Chemical Industries Limited (WBCIL) celebrates 62 years in API and nutraceutical manufacturing. Established in 1962 in Kolkata, WBCIL has emerged as a player in the pharmaceutical industry, known for its range of active pharmaceutical ingredients (APIs) and nutraceutical products.
Throughout its history, WBCIL has focused on innovation, using technology and research and development to meet global market demands.At WBCIL, Liposomal technology has been introduced harnessed to achieve next-gen bioavailability.
The company holds national accreditations, including cGMP, GLP, ISO, and FSSAI certifications, ensuring adherence to manufacturing standards. WBCIL's portfolio includes essential APIs such as Iron, Calcium, Magnesium, Potassium, and Zinc salts, alongside trace elements like Chromium, Manganese, and Copper. They produce a variety of APIs including injectable irons, chelated minerals, DC granules/premix, organic molecules, animal nutrients, and bio-active products. This company exports APIs in various corners in the world including the USA, Europe, South-east Asia and also MENA region.
WBCIL actively participates in various pharma events including CPHI Worldwide, CPHI India, CPHI China, Pharmaconex, iPHEX, Asia pharma Expo and more across the world.